Caitlin Raymond: Framing Donor Eligibility as Risk Assessment
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
“Donor infectious disease eligibility sounds straightforward — until it isn’t. I just published a new post for trainees framing donor eligibility as risk assessment, not a checklist — the way boards expect you to understand it and the way it actually works in practice. In this post I cover:
- Why some pathogens get NAT, others don’t.
- Why some are tested once, others every donation.
- Why donor history still matters in the era of ultra-sensitive testing.
If you work in transfusion medicine, blood banking, pathology, or are studying for boards, this one’s meant to connect the dots between regulations, biology, and real-world decisions.”
Title: Board Prep: Overview of Donor Infectious Disease Eligibility
Author: Caitlin Raymond

Read the full article here.
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders
-
Nov 18, 2026, 13:19Sjoerd Fabian Koopman: Exploring Tissue Distribution of Extended Half-Life Factor IX Concentrates
-
Nov 18, 2026, 13:16Ifeanyichukwu Ifechidere: Choosing Between Clot-Based and Chromogenic Coagulation Assays
-
Nov 18, 2026, 13:06Saurabh Mehta: Daily Iron Supplementation in Children and Adolescents